Montag A & Associates Inc. bought a new stake in shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP – Free Report) during the 4th quarter, Holdings Channel reports. The firm bought 1,800 shares of the company’s stock, valued at approximately $35,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Van ECK Associates Corp grew its stake in shares of Crescent Capital BDC by 2.3% during the 4th quarter. Van ECK Associates Corp now owns 45,562 shares of the company’s stock valued at $876,000 after acquiring an additional 1,006 shares during the period. Hennion & Walsh Asset Management Inc. boosted its position in shares of Crescent Capital BDC by 11.9% in the fourth quarter. Hennion & Walsh Asset Management Inc. now owns 105,343 shares of the company’s stock worth $2,025,000 after purchasing an additional 11,161 shares during the period. Redhawk Wealth Advisors Inc. purchased a new stake in shares of Crescent Capital BDC in the fourth quarter worth $659,000. Confluence Investment Management LLC increased its stake in Crescent Capital BDC by 0.9% in the 4th quarter. Confluence Investment Management LLC now owns 73,839 shares of the company’s stock worth $1,419,000 after buying an additional 633 shares in the last quarter. Finally, Franklin Resources Inc. grew its position in shares of Crescent Capital BDC by 35.2% during the third quarter. Franklin Resources Inc. now owns 256,279 shares of the company’s stock worth $4,726,000 after purchasing an additional 66,713 shares in the last quarter. Hedge funds and other institutional investors own 49.46% of the company’s stock.
Crescent Capital BDC Price Performance
NASDAQ:CCAP opened at $20.00 on Wednesday. The firm has a market capitalization of $741.20 million, a price-to-earnings ratio of 7.84 and a beta of 0.81. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.26 and a quick ratio of 1.26. The business has a 50 day simple moving average of $19.47 and a 200-day simple moving average of $18.85. Crescent Capital BDC, Inc. has a 1 year low of $16.18 and a 1 year high of $20.19.
Crescent Capital BDC Increases Dividend
Analysts Set New Price Targets
Several analysts have commented on the stock. Wells Fargo & Company boosted their price target on shares of Crescent Capital BDC from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research note on Wednesday, January 29th. Keefe, Bruyette & Woods boosted their target price on Crescent Capital BDC from $19.00 to $20.00 and gave the stock an “outperform” rating in a research report on Monday, November 25th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $19.33.
View Our Latest Stock Report on CCAP
Crescent Capital BDC Company Profile
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
See Also
- Five stocks we like better than Crescent Capital BDC
- How to Calculate Options Profits
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- How to Find Undervalued Stocks
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- How is Compound Interest Calculated?
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Want to see what other hedge funds are holding CCAP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Crescent Capital BDC, Inc. (NASDAQ:CCAP – Free Report).
Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.